Search

everythinglearnresearchcommunity

for

Search:↓

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

A woman with lupus and severe nerve damage improved with specific treatments.

circRNA-1926 helps goat stem cells turn into hair follicles by affecting miR-148a/b-3p and CDK19.

A patient lost all their hair while on rheumatoid arthritis medication.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

Neomycin is a common cause of follicular contact dermatitis, which is treated by avoiding the allergen and using creams.

COVID-19 can cause skin problems in children.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Intradermal testing can better detect corticosteroid allergies than patch testing.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

An 80-year-old man grew extra hair on his forearms after starting Alzheimer's medication rivastigmine.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Early recognition and treatment of tinea capitis are crucial to prevent severe scalp issues and prolonged therapy.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.